AND017 capsules

DRUG2 trials

Sponsors

Kind Pharmaceuticals LLC

Conditions

Anemia Due to Chronic Kidney Diseaseβ -Thalassemia

Phase 2

A Study of Safety and Efficiency of AND017 in Patients With β-thalassemia

RecruitingNCT06302491

Kind Pharmaceuticals LLCβ -Thalassemia

Start: 2024-05-27End: 2027-07-01Target: 64Updated: 2026-02-27

Phase 3

A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With Anemia

RecruitingNCT07494409

Kind Pharmaceuticals LLCAnemia Due to Chronic Kidney Disease

Start: 2025-10-31End: 2027-04-30Target: 300Updated: 2026-03-27